Igc Pharma

(NYSEMKT) IGC

Current Price$0.31

Market Cap$31.63M

Since IPO (2006)-99%

5 Year-80%

1 Year+7%

1 Month+25%

Igc Pharma Financials at a Glance

Market Cap

$31.63M

Revenue (TTM)

$1.20M

Net Income (TTM)

$5.34M

EPS (TTM)

$-0.06

P/E Ratio

-5.18

Dividend

$0.00

Beta (Volatility)

0.86 (Low)

Dividend

$0.00

Beta (Volatility)

0.86 (Low)

Price

$0.31

Volume

244,885.5

Open

$0.32

Price

$0.31

Volume

244,885.5

Open

$0.32

Previous Close

$0.32

Daily Range

$0.31 - $0.33

52-Week Range

$0.24 - $0.50

Dividend

$0.00

Beta (Volatility)

0.86 (Low)

Price

$0.31

Volume

244,885.5

Open

$0.32

Previous Close

$0.32

Daily Range

$0.31 - $0.33

52-Week Range

$0.24 - $0.50

IGC News

Man Worried About Sinking Stock Market Chart Getty

Why Marijuana Stocks Tilray, New Age Beverages, and India Globalization Capital Slumped Today

Dan CaplingerOct 9, 2018

The 3 Most Dangerous Marijuana Stocks

Sean WilliamsOct 9, 2018

This New Cannabis Craze Has Made Early Investors Rich

Dan CaplingerOct 4, 2018

Why Century Aluminum, Select Income REIT, and India Globalization Capital Slumped Today

Dan CaplingerOct 3, 2018

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Igc Pharma

Industry

Pharmaceuticals

Sector

Health Care

Employees

CEO

Ram Mukunda

Website

www.igcpharma.com

Headquarters

Potomac, MD 20854, US

IGC Financials

Key Financial Metrics (TTM)

Gross Margin

33%

Operating Margin

-8%

Net Income Margin

-4%

Return on Equity

-78%

Return on Capital

-1%

Return on Assets

-55%

Earnings Yield

-19.31%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$31.63M

Shares Outstanding

98.80M

Volume

244.89K

Avg. Volume

1.06M

Financials (TTM)

Gross Profit

$619.00K

Operating Income

$7.45M

EBITDA

$6.83M

Operating Cash Flow

$4.79M

Capital Expenditure

$482.00K

Free Cash Flow

$5.28M

Cash & ST Invst.

$405.00K

Total Debt

$238.00K

Igc Pharma Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q3 2026YOY CHG

Revenue

$350.00K

+36.2%

Gross Profit

$6.00K

-105.8%

Gross Margin

-1.71%

N/A

Market Cap

$31.63M

N/A

Market Cap/Employee

$472.16K

N/A

Employees

N/A

Net Income

$726.00K

+60.3%

EBITDA

$2.88M

-67.2%

Quarterly Fundamentals

Name

Q3 2026YOY CHG

Net Cash

$796.00K

+990.4%

Accounts Receivable

$12.00K

-75.5%

Inventory

$653.00K

-54.4%

Long Term Debt

$133.00K

-8.9%

Short Term Debt

$9.00K

-96.4%

Return on Assets

-55.01%

N/A

Return on Invested Capital

-1.21%

N/A

Free Cash Flow

$1.24M

+8.1%

Operating Cash Flow

$1.22M

+7.1%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

BOLDBoundless Bio, Inc.

BOLDBoundless Bio, Inc.$1.48+0.52%

SABSSAB Biotherapeutics, Inc.

SABSSAB Biotherapeutics, Inc.$3.51+1.15%

PLURPluri Inc.

PLURPluri Inc.$3.20-5.04%

NXTCNextCure, Inc.

NXTCNextCure, Inc.$9.54-0.78%

NTRBNutriband Inc.

NTRBNutriband Inc.$3.86-0.72%

PSTVPlus Therapeutics, Inc.

PSTVPlus Therapeutics, Inc.$6.15+2.67%

INTSIntensity Therapeutics, Inc.

INTSIntensity Therapeutics, Inc.$5.19-1.70%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$10.84+0.01%

POETPoet Technologies

POETPoet Technologies$7.92-0.00%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$12.07-0.02%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$60.23-0.04%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.14+0.07%

BBBYBeyond, Inc.

BBBYBeyond, Inc.$5.10-0.04%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$54.67+0.04%

Questions About IGC

What is the current price of Igc Pharma?

Igc Pharma is trading at $0.31 per share.

What is the 52-week range for Igc Pharma?

Over the past 52 weeks, Igc Pharma has traded between $0.24 and $0.50.

How much debt does Igc Pharma have?

As of the most recent reporting period, Igc Pharma reported total debt of $142,000.

How much cash does Igc Pharma have on hand?

Igc Pharma reported $900,000 in cash and cash equivalents in its most recent financial results.

What is Igc Pharma’s dividend yield?

Igc Pharma does not currently have a dividend yield.

Igc Pharma

Igc Pharma Financials at a Glance

IGC News

Marijuana Train Wreck: These 19 Pot Stocks Lost 20% (or More) in October

This Pot Stock Just Got Booted Off the NYSE

Cannabis-Infused Beverages: 3 Things You May Not Realize

Why Marijuana Stocks Tilray, New Age Beverages, and India Globalization Capital Slumped Today

The 3 Most Dangerous Marijuana Stocks

This New Cannabis Craze Has Made Early Investors Rich

Why Century Aluminum, Select Income REIT, and India Globalization Capital Slumped Today

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Igc Pharma

IGC Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Igc Pharma Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About IGC

What is the current price of Igc Pharma?

What is the 52-week range for Igc Pharma?

How much debt does Igc Pharma have?

How much cash does Igc Pharma have on hand?

What is Igc Pharma’s dividend yield?

Premium Investing Services